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8 ABSTRACT: Ag2S semiconductor nanoparticles (NPs) are near-infrared luminescent
9 probes with outstanding properties (good biocompatibility, optimum spectral operation
10 range, and easy biofunctionalization) that make them ideal probes for in vivo imaging.
11 Ag2S NPs have, indeed, made possible amazing challenges including in vivo brain imaging
12 and advanced diagnosis of the cardiovascular system. Despite the continuous redesign of
13 synthesis routes, the emission quantum yield (QY) of Ag2S NPs is typically below 0.2%.
14 This leads to a low luminescent brightness that avoids their translation into the clinics. In
15 this work, an innovative synthetic methodology that permits a 10-fold increment in the
16 absolute QY from 0.2 up to 2.3% is presented. Such an increment in the QY is
17 accompanied by an enlargement of photoluminescence lifetimes from 184 to 1200 ns. The
18 optimized synthetic route presented here is based on a fine control over both the Ag core
19 and the Ag/S ratio within the NPs. Such control reduces the density of structural defects
20 and decreases the nonradiative pathways. In addition, we demonstrate that the superior
21 performance of the Ag2S NPs allows for high-contrast in vivo bioimaging.
22 KEYWORDS: Ag2S/Ag nanoparticles, fluorescent probes, synthesis optimization, PL lifetime, PLQY, NIR-II imaging
1. INTRODUCTION
23 Biomedical imaging techniques are used routinely in clinical
24 practice as they provide physiological information of organs/
25 tissues of living beings that is, otherwise, unreachable.1,2 These
26 noninvasive techniques allow the diagnose and/or prognosis of
27 different diseases and have gained increasing interest in clinical
28 and medical research. Among them, computed tomography
29 (CT), positron emission tomography (PET) or single-photon
30 emission tomography (SPECT), magnetic resonance imaging
31 (MRI), ultrasonography (Echo), and optical coherent
32 tomography are by far the most used techniques. However,
33 some drawbacks such as the use of ionizing radiation (CT,
34 PET, and SPECT), limited spatial resolution (MRI, Echo, and
35 PET), poor temporal resolution (CT, MRI, PET, and
36 SPECT), and complex and expensive instrumentation restrict
37 their access to third-level hospitals.3,4
38 Some of these drawbacks are overcome by near-infrared
39 (NIR) fluorescent imaging in the so-called second NIR
40 window, which ranged between 1000 and 1700 nm and
41 characterized by the reduction of the scattering and absorption
42 of tissues.5,6 In vivo imaging in this spectral range has been
43 widely demonstrated to provide better imaging resolution at
44 larger depths into tissues.7 The simplicity of the instrumenta-
45tion as well as the high spatial and temporal resolution has
46facilitated, for instance, its use in medical research, where
47animal models are used to study the localization and evolution
48of diseases, thus facilitating a successful translation from
49research to clinical practice.8,9 However, apart from being
50biocompatible, one of the major challenges to widen its
51application is related to the low quantum yield (QY) of most
52of the NIR fluorescent probes. For instance, Dai’s group has
53reported organic compounds that emit in the NIR-II region,
54which can be used as fluorescent NIR-II probes.10 Among
55them, CH1055, a conjugated organic molecule with good
56biological features, has shown a QY of 0.4%,11 while other
57organic compounds, such as cholate-functionalized single-wall
58carbon nanotubes, have shown a relative QY of 0.84%.12
59Inorganic nanoparticles (NPs) based on heavy metal ions such
60as PbS or CdHgTe have excellent fluorescent properties in the
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61 NIR-II region with a QY of about 40%;13,14 however, these
62 classes of NPs have been discarded because of their known
63 acute and chronic toxicity.15,16
64 Silver chalcogenides can be considered as promising
65 alternative candidates for NIR-II fluorescent imaging because
66 of their negligible toxicity and high photostability.17−19
67 However, their low luminescence brightness is still a big
68 obstacle that limits their application for high-contrast, deep
69 tissue in vivo imaging. Many works dealing with Ag2S NP
70 obtain the QY as high as 10%;20,21 however, most of these
71 results are obtained by comparison with NIR-II fluorescent
72 dyes that do not match with the absolute QYs measured with
73 an integrating sphere and which are typically below 1%.22
74 These low QYs agree with short photoluminescence (PL)
75 lifetimes observed in these NP, ranging between 50 and 200 ns,
76 which reveal the dominant role of nonradiative pathways
77 within the emission process.23,24 These nonradiative processes
78 are associated with the presence of certain regions on the
79 surface of the NP that act as charge acceptors, dissociating
80 excitons and therefore reducing the PL efficiency.25 Some of
81 these traps are related to variations in solvent or surface-bound
82 coordinating ligands (dangling bonds) that influence the
83 steady-state, time-resolved PL and QY.26 In addition, structural
84 defects in the crystalline structure can also strongly affect the
85 PL efficiency of the NPs because they induce the formation of
86 midgap states that favor non-PL pathways and reduce the PL
87 efficiency of the NPs.27 Furthermore, in the case of Ag2S NPs,
88 the high redox potential of silver ions and the high temperature
89 used during their synthesis can lead to the formation of a
90 metallic silver core when the reaction is carried out in the
91 presence of amines, forming Ag+−amine complexes that are
92 highly reactive and can form Ag2S as well as Ag NPs.
28,29 To
93 minimize the formation of the metallic silver core, different
94 authors have proposed to remove, totally or partially, the
95 presence of amine-bearing molecules and use dodecanethiol
96 instead, thereby reducing the reactivity and passivating the
97 surface of the NPs.30 However, the resulting NPs still
98 presented low QY31 as well as short PL lifetimes.32,33
99 In this work, we have developed a new synthesis route
100 toward the improvement of the fluorescence properties of Ag2S
101 NPs. A systematic study of the steady-state luminescence,
102 emission lifetime, and absolute QYs of NPs with different
103 metallic silver contents demonstrates that the presence of a
104 specific amount of metallic silver within the NPs increases the
105 QY of the NPs by more than 1 order of magnitude. This
106 increment is concomitant with an enlargement of the PL
107 lifetime which scales from 180 to 1220 ns as well as an
108 emission red shift of the produced Ag2S/Ag NPs. The potential
109 use of the improved Ag2S NPs for high-contrast in vivo
110 imaging in the second biological window has also been
111 evaluated.
2. EXPERIMENTAL SECTION
112 2.1. Chemicals. Silver nitrate (99%), sodium diethyldithiocarba-
113 mate (NaDDTC) (ACS reagent grade), oleylamine (70%) (OLA), 1-
114 dodecanethiol (≤98%) (DDT), 11-mercaptoundecanoic acid (95%)
115 (MUA), CHCl3 (99.6%), ethanol (99.9%), N-(3-(dimethylamino)-
116 propyl)-N′-ethylcarbodiimide hydrochloride (EDC) (99%), N-
117 hydroxysulfosuccinimide sodium salt (sulfo-NHS) (98%), O-(2-
118 aminoethyl)-O′-methyl-polyethylene glycol (PEG-NH2, Mp = 5000
119 g/mol), and phosphate-buffered saline (PBS) tablets were purchased
120 from Sigma-Aldrich and used as received. Commercial Ag2S-PEG NPs
121 were bought from NIR Optics Technology.
1222.2. Characterization. Transmission electron microscopy (TEM)
123studies were carried out using a TEM Talos F200X operated at 80 kV.
124Zeta potential experiments were carried out using a Malvern Nano-
125ZS. The Fourier transform infrared (FTIR) spectra were obtained
126using a Nicolet IR200 FTIR spectrometer. X-ray diffraction (XRD)
127patterns were recorded on a Philips X’pert diffractometer (Cu Kα
128radiation, 45 kV, and 40 mA). Data were collected from 2θ = 20−90°
129with a step size of 0.02° and a normalized count time of 1 s/step. The
130emission spectra upon illuminating the samples with an 800 nm CW
131laser were collected with an Andor iDus InGaAs 491 cooled to −90
132°C. The absolute PL QY was measured with a calibrated
133spectrofluorometer (Edinburgh Instruments, FLS920) equipped
134with an integrating sphere (Jobin-Yvon). A Xe lamp has been used
135as the excitation source and filtered with a long-pass filter (610 nm)
136and a monochromator (wavelength: 800 nm, bandwidth: 20 nm).
137Luminescence was detected by a liquid-nitrogen-cooled NIR
138photomultiplier tube (Hamamatsu, R5509-72). The QY has been
139calculated by dividing the total number of emitted photons in the
140900−1700 nm range by the total number of absorbed photons at 800
141nm. Luminescence decay curves were obtained by exciting the
142colloidal suspensions of NPs by an OPO oscillator (Lotis) tuned to
143800 nm, which provides 8 ns pulses at a repetition rate of 10 Hz.
144Fluorescence intensity was detected with a Peltier cooled photo-
145multiplier tube with enhanced sensitivity in the NIR-II (Hamamatsu
146R5509-73). The contribution of scattered laser radiation was removed
147by using two band-pass filters (FEL850 from Thorlabs) and a high-
148brightness monochromator (Shamrock 320 from Andor). The time
149evolution of the fluorescence signal was finally recorded and averaged
150by a digital oscilloscope (LeCroy WaveRunner 6000).
151High-angle annular dark-field (HAADF) scanning TEM (STEM)
152and energy-dispersive X-ray (EDX) mappings were conducted by
153using a FEI Talos F200X (FEI, USA) coupled to an EDX detector.
154The samples for TEM were prepared by adding 10 μL of each
155dispersion on a Cu grid with a carbon support membrane, followed by
156drying.
1572.3. In Vivo Imaging. NIR-II in vivo images were obtained in a
158homemade NIR-II system. A fiber-coupled diode laser operating at
159800 nm was used as the excitation source (LIMO30-F200-DL808).
160The illumination intensity was controlled via adjustment of diode
161current. An anesthetized mouse was placed on a homemade
162temperature-controlled plate operating at 36 °C. The NIR-II
163fluorescence image was acquired with a Peltier cooled InGaAs
164camera (Xeva 320 from Xenics). The InGaAs detector was cooled
165down to −40 °C. Two long-pass filters (FEL850 from Thorlabs) were
166used to remove the background signal generated by the scattered laser
167radiation.
168In vivo experiments were approved by the regional authority for
169animal experimentation of Comunidad de Madrid and were
170conducted in agreement with the Universidad Autońoma de Madrid
171(UAM) Ethics Committee, in compliance with the European Union
172directives 63/2010UE and Spanish regulation RD 53/2013. For this
173study, a total of 15 CD1 female mice (8−14 weeks old, weighing 25−
17439 g) bred at the animal facility at UAM were used. The mice were
175anesthetized prior to the imaging experiments in an induction
176chamber with a continuous flow of 4% isoflurane (Forane, AbbVie
177Spain, S.L.U) in 100% oxygen until loss of righting reflex was
178confirmed and breathing rhythm was significantly slowed. Anesthesia
179was maintained throughout the experiments by means of facemask
180inhalation of 1.5% isoflurane and the core body temperature was
181maintained at 36 ± 1 °C, as measured with a rectal probe, using a
182heating pad.
1832.4. Synthesis of Ag2S/Ag-PEG NPs. The synthesis of the Ag2S/
184Ag-PEG NPs was carried out in different steps as explained in the
185following sections.
1862.4.1. Synthesis of Ag2S/Ag NPs. The production of Ag2S/Ag NPs
187was carried out as follows: a given amount of Ag(DDTC) (typically
18825 mg, 0.1 mmol) was added into a two-neck round-bottom flask at
189room temperature, which contained 5 mL of a solvent mixture based
190on OLA and DDT. Table S1 shows the solvent mole fraction (χDDT)
191used in each synthesis, where χDDT = [nDDT/(nDDT + nOLA)]. Once all
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192 the reagents were introduced into the flask, the mixture was subjected
193 to vacuum for 10 min to remove air and then filled with N2. After that,
194 the mixture was heated to 190 °C under magnetic stirring with a
195 heating rate of 20 °C/min and under slow magnetic stirring. The
196 reaction was kept for 1 h and subsequently cooled down naturally.
197 The synthesized NPs were collected by addition of ethanol, which
198 reduces the colloidal stability of the NPs. To do that, 10 mL of
199 ethanol was added to the raw product and centrifuged at 10,000 rpm
200 for 10 min; this process was repeated twice. Finally, the as-prepared
201 product was dispersed in 10 mL of chloroform and stored for further
202 steps.
2032.4.2. PEGylation of Ag2S/Ag Heterodimers. With the aim of
204providing hydrophilicity to the synthesized NPs, they were treated
205with MUA. This molecule can displace the hydrophobic ligands on
206the surface of the NPs and introduce carboxylic groups on the surface
207of the NPs, thereby providing good colloidal stability in water. With
208that purpose, 20 mg (0.1 mmol) of MUA was added to a 1 mL
209dispersion containing 1 mg/mL of Ag2S/Ag NPs in chloroform at
210room temperature. After that, the mixture was sonicated in an
211ultrasonic bath for 10 min until the Ag2S/Ag NPs lose their colloidal
212stability and precipitated at the bottom of the flask. Then, the
213precipitate was collected and dispersed in 1 mL of PBS at pH 7.4.
Figure 1. HAADF−STEM micrographs of NPs obtained under different synthetic conditions (from A1 to F1). The insets from A2 to F2 represent
the EDS elemental mapping of silver, while the insets from A3 to F3 depict the EDS elemental mapping of sulfur. From A4 to F4, merged figures
resulting from the HAADF−STEM and EDS elemental analysis are showed. The insets from A5 to F5 show detailed magnifications of the merged
EDS and HAADF−STEM micrographs.
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214 Subsequently, these NPs were covered with PEG-NH2 (Mp = 5000 g/
215 mol) via EDC/NHS coupling. To do that, 0.5 mg of EDC and 0.7 mg
216 of sulfo-NHS were dissolved in 1 mL of PBS containing 1 mg of the
217 previously prepared Ag2S/Ag containing MUA ligands and 1 mg of
218 PEG-NH2. The mixture was gently stirred for 2 h, and after that, the
219 NPs were collected by centrifugation at 12,000 rpm for 2 h. This
220 process was repeated three times and the resulting NPs were
221 dispersed in 1 mL of PBS and stored at 4 °C.
3. RESULTS AND DISCUSSION
f1 222 Figure 1 depicts the HAADF−STEM images of the Ag2S NPs
223 synthesized using different solvent ratios. As observed, all the
224 NPs exhibit two well-differentiated regions, a white area with
225 higher Z-contrast, corresponding to the electrodense parts of
226 the NPs, probably due to the presence of metallic Ag into the
227 NPs. In addition, the figure shows the existence of less
228 electrodense areas that appear as gray regions, corresponding
229 to Ag2S.
230 The energy-dispersive spectrometry (EDS) elemental
231 mappings showed in Figure 1 reveal the anisotropic spatial
232 distribution of Ag (red) and S (green) within the NPs. These
233 micrographs unveil the presence of Ag-enriched regions that
234 overlap with those that exhibited higher Z-contrast (white
235 regions in the HAADF−STEM micrographs). Interestingly,
236 this silver core appears more eccentrically located when lower
237 χDDT is used during the synthesis. The synthetic conditions
238 induce variations in the structure and properties of the
239 synthesized NPs. In fact, a decrease in overall NP size can be
240 clearly correlated with an increase of χDDT during the reaction.
241 Figure S2 shows the average size of each synthesis as well as
242 the size of the electrodense region that corresponds to the
243 silver core. This result can be explained in terms of the higher
244 capacity of the DDT molecules to interact with the NPs
245through the thiol group, which exhibits the highest binding
246energy toward noble metals (200 kJ/mol).34 Therefore, a high
247χDDT (high amount of DDT) leads to an increased colloidal
248stability of small NPs formed during the course of the reaction
249and thus preventing the particles from aggregation, resulting in
250a smaller overall NP size.
251The XRD patterns of these NPs reveal the presence of two
252crystalline phases, which could be attributed to monoclinic
253Ag2S (JCPDS card no. 14-0072; lattice constants: a = 4.229 Å,
254b = 6.931 Å, and c = 7.862 Å) and cubic Ag (JCPDS card no.
25504-0783; lattice constants: a = 4.0862 Å), as can be seen in
256Figure S3. A more detailed analysis of the XRD patterns can be
257found in the Supporting Information. With the aim of
258completing the structural and compositional characterization,
259X-ray photoelectron spectroscopy and XANE analysis have
260been carried out. The wide-scan survey spectra of the NPs
261show the presence of Ag 3d (364, 374 eV) and S 2p (161,
262162.2 eV) doublets as well as C 1s (285 eV) and O 1s (532
263eV). High-resolution scans of Ag 3d spectra are shown in
264Figure S4A. The deconvolution of the Ag 3d binding energy
265spectra is fitted with two silver doublets. The Ag+ binding
266energy of the peaks centered at 372.2 eV (3d3/2) and 366.6 eV
267(3d5/2) could be attributed with Ag2S, whereas those peaks at
268373.6 eV (3d3/2) and 367.5 eV (3d5/2) could be related with
269Ag0, see Figure S4B. Complementary analyses by X-ray
270absorption near-edge structure (XANES) for the Ag K-edge
271spectra of the synthesized NPs have also been carried out. This
272technique permits determining the oxidation state of the Ag
273atoms that constitute the sample. The oxidation state of the
274samples was analyzed by a linear combination fitting
275procedure, as can be seen in Figure S6. The result of these
276analyses shows that in both cases, the NPs are constituted by a
Figure 2. (A) Normalized UV−vis spectra of the NPs synthesized under different solvent ratios. (B) PL spectra of the NPs synthesized under
different conditions dispersed in CHCl3 at a concentration of 1 mg/mL (exc. 800 nm). Insets (B1,B2) show the variation of the maximum of the
emission wavelength and the maximum of the PL intensity as a function of solvent ratio. (C) PL decay curves of the different NPs. (D) Lifetimes
and absolute QYs as a function of solvent ratio. The color legend is as follows: Ag2S-0.00, cyan; Ag2S-0.15, red; Ag2S-0.30, green; Ag2S-0.60, blue;
Ag2S-0.90, orange; and Ag2S-1.00, black, with numeric values indicating the χDDT.
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277 predominant phase of Ag2S and a metallic Ag counterpart in a
278 ratio 0.75:1. Furthermore, we have performed Fourier
279 transform extended X-ray absorption fine structure of both
280 types of NPs, as can be seen in Figure S7. As one can observe,
281 both samples (Ag2S-0 and Ag2S-06) exhibit two main peaks,
282 one located at 2 Å, which matches perfectly with the Ag−S
283 distance in the Ag2S phase, and a second peak located at 2.8 Å,
284 which is characteristic of the Ag−Ag distance in the metallic
285 Ag phase, and we can conclude that the synthesized Ag2S NPs
286 have a metallic Ag phase within the structure.
f2 287 Figure 2 summarizes the impact of the synthetic conditions
288 on the spectroscopic properties of the NPs (absorption, PL,
289 lifetime, and QY). Figure 2A shows the normalized absorption
290 spectra for all samples in the range between 300 and 900 nm.
291 In all cases, a strong absorption in the visible region with a
292 weak shoulder at 465 nm and a long tail until the NIR region
293 can be observed. The shoulder at ∼465 nm may be attributed
294 to the plasmonic contribution of the metallic Ag present in the
295 NP.35,36 It is important to note that this band only appears in
296 those syntheses in which OLA is used. This indicates the role
297 of the amino groups in the formation of metallic silver during
298 the synthesis of NPs at high temperatures.33 In fact, it is well
299 known that during the synthesis of Ag2S NPs through the
300 thermal decomposition of a silver precursor, such as Ag-
301 monothiobenzoate or Ag-diethyldithiocarbamate, metallic Ag
302 nanocrystals are formed as the side products.37,38 This is
303 because the dissociation energy of the Ag−S bond (206.45 kJ/
304 mol) is lower compared to that of the S−C bond (265.95 kJ/
305 mol), and, under a heating up process, Ag ions are released in
306 the absence of reactive sulfur.39 The addition of alkylamines in
307 the reaction may lower the dissociation energy of the S−C
308 bonds of the silver precursor via nucleophilic addition of an
309 amine to the carbonyl group, thereby potentially providing a
310 higher amount of reactive sulfur in the reaction, resulting in an
311 increased Ag2S formation.
40 Such an effect can be observed in
312 Figure S1; here, one can observe the reduction of the size of
313the Ag2S matrix when increasing the χDDT, while the size of the
314Ag core remains unchanged.
315Figure 2B shows the emission band of the different samples
316as obtained under 800 nm optical excitation. The emission
317band is clearly affected by the synthesis conditions. First, we
318observe that the peak wavelength is red-shifted when
319increasing the χDDT. In fact, the NPs synthesized only in the
320presence of OLA exhibit its maximum emission at 1160 nm,
321while those synthesized using only DDT as a solvent showed
322its emission peak at 1220 nm. These variations indicate an
323increment in the band gap of the NPs when increasing the
324χDDT, which cannot be attributed to quantum confinement
325effects because the size of all these NPs are well above the Bohr
326radius of Ag2S.
41,42 Another effect observed is a prominent
327variation of the luminescence emission intensity as a χDDT,
328which could be related to different emission efficiencies. For a
329better understanding, the luminescence decay times of the NPs
330were measured, see Figure 2C. From these results, we can
331observe an enhancement of the NP lifetimes from 120 to 1200
332ns when increasing the χDDT up to 0.60, see Figure 2D. Such an
333increment of the lifetimes is concomitant with the enhance-
334ment of the QY that increases from 0.2 to 2.3%. Surprisingly, a
335further increase of χDDT provoked a subsequent reduction of
336the lifetimes from 1200 to 180 ns as well as the QY values,
337from 2.4% down to 0.2%. For the lowest and the highest χDDT
338values, decreased PL lifetimes and QYs could be attributed to
339the increment of nonradiative pathways in the NPs. All these
340results allowed us to identify the optimal synthetic conditions
341for the production of highly efficient Ag2S NPs.
342In order to understand how synthetic conditions could affect
343the emission of the NPs, we have analyzed the composition of
344the generated NPs by EDS mapping profile, as can be seen in
345 f3Figure 3. It is evidenced how the synthetic conditions affect
346tremendously the size, shape, position of the Ag-enriched core,
347and also the atomic ratio of Ag/S within the NPs. In fact, the
348analysis of the NET X-ray profile of those NPs synthesized
Figure 3. EDS mapping profile of the Ag2S/Ag NPs (A,D,G). Net X-ray profile extracted from the yellow arrow marked in the STEM images
(B,E,H). Merged STEM and NP model images represented as a function of Ag/S ratio vs the probe position (B,E,H). Frequency distribution of the
Ag/S ratio in the NPs excluding the silver core (C,F,I). The NPs used for EDS mapping were derived using χDDT of 0.00 (A,B), 0.60 (D−F), and
1.00 (G−I) during the synthesis.
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349 with neat OLA (χDDT of 0.00, Figure 3A) allows to infer the
350 Ag/S atomic ratio profile of such NPs as can be seen in Figure
351 3B that is characterized by the presence of peaks that match
352 with the position of the silver-enriched region, while the rest of
353 the regions present Ag/S atomic ratios around 2. When we
354 represent the frequency distribution of the Ag/S ratio obtained
355in these NPs, we can observe the presence of two Gaussian
356populations, one centered at 1.8 and the other at 2.2, which
357differs from a theoretical ratio of 2, which should correspond
358to a perfect Ag2S matrix (Figure 3C). Such a result would
359indicate the presence of compositional inhomogeneities in the
360Ag2S matrix that could render in structural defects. This fact
Figure 4. (A) Schematic representation for the surface modification of the NPs by ligand-exchange reaction with MUA and its subsequent
PEGylation through the EDC/sulfo-NHS coupling reaction. Graphic (B) evolution of the NP hydrodynamic diameter during the surface
functionalization process. (C) PL decay times of Ag2S/Ag NPs in CHCl3 (green), Ag2S/Ag-PEG NPs in PBS at a concentration of 1 mg/mL
(blue), and Ag2S-PEG NPs synthesized by Zhang’s method in PBS at a concentration of 1.5 mg/mL (red).
Figure 5. (A) In vivo imaging of an anesthetized mouse 5 min after intravenous injection of the thus optimized Ag2S NPs. The animal was optically
excited with an 800 nm laser diode with a power density of 45 mW/cm2, and luminescence (1000−1400 nm) was recorded with an infrared
camera. (B) Magnification of the lower extremities where the femoral vessels can be observed. (C) Cross-sectional intensity profile measured along
the black dashed line in (B). (D) Ex vivo NIR-II image of the skeleton and (E) lungs, spleen, and liver of the dissected mouse and (F) detailed
image of femur, tibia, ilium, and sacrum of mice.
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361 would explain the low QY observed in this sample.43
362 Interestingly, those NPs synthesized using a χDDT of 0.60
363 depict the NET X-ray profile different from the previous NPs,
364 see Figure 3D. That informs us of Ag/S ratios very close to 2
365 for those areas distinct to the silver-enriched regions, as can be
366 seen in Figure 3G. When we represent the frequency
367 distribution of the Ag/S ratio, we obtain a mean value
368 centered at 1.9, which is closer to the hypothetical ratio of 2 of
369 the Ag2S matrix and would indicate the reduction of possible
370 defects as shown in Figure 3F. This would be the reason why
371 these NPs exhibit an increment of the static emission as well as
372 the PL lifetime and QY. Finally, in the case of those NPs
373 synthesized in the presence of neat DDT (χDDT of 1.00), the
374 NET X-ray profile shows the presence of a high concentration
375 of silver, located preferentially in the core of the NPs, Figure
376 3G. Such a profile creates a rapid increment of the Ag/S
377 atomic ratio from a S-enriched surface to a Ag-enriched core,
378 resulting in a very small region where the matrix composition
379 could be Ag2S, decreasing the NIR fluorescence of these NPs,
380 as shown in Figure 3H. On the contrary, the frequency
381 distribution of the Ag/S ratio does not permit us to observe
382 any maximum close to 2, which would indicate the presence of
383 a thin Ag2S region surrounded by structural defects, which
384 would render Ag2S NPs with poor luminescent properties as
385 observed in Figure 3I.
386 The optimized (from synthesis with χDDT of 0.60 with
387 largest QY and luminescence lifetime) Ag2S NPs were tested as
388 NIR-II in vivo imaging contrast agents. To do that, ligand-
389 exchange reaction is carried out to substitute the hydrophobic
f4 390 capping agents by hydrophilic, thiol-bearing molecules for their
f4 391 stabilization in aqueous media. Figure 4A shows the ligand-
392 exchange process. In the first step, carboxylic acid terminated
393 MUA ligands are introduced on the surface of the NPs, thereby
394 acquiring negative charges which are confirmed by the zeta
395 potential measurements giving a value of ∼−27 mV. The
396 hydrodynamic diameter of the MUA-functionalized NPs is 14
397 ± 7 nm in PBS. After that, carboxylic groups were used as
398 anchoring points, allowing for the linkage of PEG-NH2
399 molecules (5 kDa) through the amino-terminated group,
400 performing a coupling reaction mediated by EDC and sulfo-
401 NHS. The products of this reaction are PEG-modified NPs
402 with a hydrodynamic diameter of 20 ± 9 nm and a zeta
403 potential of −16 mV, which is still negative because of the
404 presence of the remaining carboxylate groups on the surface of
405 the NPs that did not react with PEG, as can be seen in Figure
406 4. After the ligand-exchange reaction, the luminescence lifetime
407 decreased as evident in Figure 4C, when these NPs were
408 coated with PEG and transfer to PBS, the lifetime suffered a
409 reduction from 1200 ns down to 379 ns. The observed
410 reduction of the lifetime can be associated with the
411 environment-assisted multiphoton relaxation processes, when
412 the NPs are dispersed in water, as it was previously observed.24
413 For the sake of comparison, we also measured the
414 luminescence decay time of commercially available Ag2S-
415 PEG NPs in PBS (see Figure 4C). Note that our “optimized”
416 Ag2S NPs showed a significantly increased luminescence decay
417 time, revealing the effective reduction of nonradiative decays
418 because of the improved Ag and S ratio in the final matrix.
419 In order to demonstrate the potential of the “optimized”
420 Ag2S NPs for in vivo imaging, 150 μL of a solution with a NP
421 concentration of 1 mg/mL was injected in 1 month-old CD1
422 female mice via retro-orbital injection. The anesthetized mouse
423 was illuminated with a low-power 800 nm laser diode
424providing an on-target laser power density as low as 45
425mW/cm2. The luminescence generated by the Ag2S NPs was
426registered by an InGaAs infrared camera. In order to avoid any
427contribution of laser-reflected light to the fluorescence image, a
428 f51000 nm long-pass filter was used. In Figure 5A, an optical plus
429infrared fluorescence-merged image of the mouse, as obtained
4305 min after the injection of the NPs, is shown. A clear
431luminescence signal is detected at the abdominal area of the
432mouse, which is attributed to a fast accumulation of NPs in the
433liver. Although the highest intensity is detected from the liver,
434a detailed inspection of the subabdominal region also reveals
435clear fluorescence contrast. The zoom included in Figure 5B
436reveals the presence of NPs in the bloodstream. In particular,
437vessels of the lower limbs are evident in the amplified
438fluorescence image. Indeed, it is clear that, even by using this
439low excitation power density and low magnification optics, the
440optimized Ag2S NPs are bright enough to provide an image of
441the vessel anatomy with a submillimeter spatial resolution (see
442intensity profile in Figure 5C). In order to elucidate the
443biodistribution of the injected NPs, the animal was sacrificed 1
444h after injection, and the presence of Ag2S in the different
445organs was elucidated from their fluorescence images. Figure
4465D shows the fluorescence image corresponding to the
447skeleton, indicating the partial accumulation of Ag2S NPs
448within the bones. Figure 5E includes the infrared fluorescence
449images corresponding to the liver, spleen, and lungs. Only
450these organs provided any relevant infrared fluorescence. This
451fact indicates that 1 h postinjection, the Ag2S NPs were
452accumulated at the bones, lungs, liver, and spleen. Similar
453biodistribution patterns were already reported by other
454authors.44,45 Finally, Figure 5F shows an amplified fluorescence
455image of the bone structure of a limb. Note how the
456accumulation of Ag2S NPs at the bones opens the way of
457obtaining high-resolution images of the skeleton by infrared
458fluorescence imaging. At this point, we would like to stress that
459the accumulation of Ag2S NPs at bone structures could not
460only be used for advanced in vivo imaging of the bone
461structure but it can also be used for therapeutic effects. Note
462that Ag2S NPs are also known to be excellent luminescent
463nanothermometers. This means that they could be potentially
464used to measure the intrabone temperature. This, in turns,
465becomes essential to achieve full control over photothermal
466therapies of bones, which have been recently demonstrated to
467be of high efficacy to promote bone regeneration.46−48
4. CONCLUSIONS
468The present work demonstrates the crucial role of the synthetic
469conditions on the PL properties of Ag2S NPs. More in detail,
470the effect of the solvent ratio of DDT and OLA during the NP
471generation via thermal degradation using Ag(DDTC) was
472evaluated. In total, six different solvent ratios were tested (χDDT
473of 0.00, 0.15, 0.30, 0.60, 0.90, and 1.00). From a structural
474point of view, a clear decrease in NP size with an increase of
475DDT was observed, assumingly correlated with a more
476pronounced stabilization of small NPs by the thiol-bearing
477solvent DDT. Regarding the photoluminescent properties, a
478maximum of luminescence lifetimes and QY was observed for
479NPs generated with a χDDT of 0.60. The measured
480luminescence lifetimes reached values of 1200 ns in
481comparison to lifetimes of 120 and 180 ns for the NPs
482synthesized using χDDT of 0.00 and 1.00, respectively. For the
483QY, a 10-fold higher value of 2.3% was determined for the NPs
484synthesized with a χDDT of 0.60 compared to the NPs derived
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485 from neat solvents. As studied by the EDS mapping of the
486 generated NPs using χDDT of 0.00, 0.60, and 1.00, we were able
487 to clearly correlate the improved photoluminescent properties
488 to a more precise ratio of Ag and S in the final NP matrix. In
489 addition, the surface modification of the Ag2S NPs allows for a
490 transfer into aqueous solution. In this media, our fabricated
491 Ag2S NPs conserve the superb optical properties, exhibiting
492 higher luminescence lifetimes and QY compared to commer-
493 cially available PEGylated Ag2S in aqueous buffer. This permits
494 their usage as contrast imaging agents, where the NPs present
495 an excellent biodistribution.
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550Autońoma de Madrid, Madrid 28049, Spain
551Christoph Gerke − Departamento de Quiḿica en Ciencias
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685Gonzaĺez-Calbet, J. M.; Juaŕez, B. H. Synthesis and characterization of
686Ag2S and Ag2S/Ag2(S,Se) NIR nanocrystals. Nanoscale 2019, 11,
6879194−9200.
(23) 688Jiang, P.; Tian, Z.-Q.; Zhu, C.-N.; Zhang, Z.-L.; Pang, D.-W.
689Emission-Tunable Near-Infrared Ag2S Quantum Dots. Chem. Mater.
6902011, 24, 3−5.
(24) 691Santos, H. D. A.; Ruiz, D.; Lifante, G.; Jacinto, C.; Juarez, B. H.;
692Jaque, D. Time resolved spectroscopy of infrared emitting Ag2S
693nanocrystals for subcutaneous thermometry. Nanoscale 2017, 9,
6942505−2513.
(25) 695Zhang, Y.; Liu, Y.; Li, C.; Chen, X.; Wang, Q. Controlled
696Synthesis of Ag2S Quantum Dots and Experimental Determination of
697the Exciton Bohr Radius. J. Phys. Chem. C 2014, 118, 4918−4923.
(26) 698Giansante, C.; Infante, I. Surface Traps in Colloidal Quantum
699Dots: A Combined Experimental and Theoretical Perspective. J. Phys.
700Chem. Lett. 2017, 8, 5209−5215.
(27) 701Boles, M. A.; Ling, D.; Hyeon, T.; Talapin, D. V. Erratum: The
702surface science of nanocrystals. Nat. Mater. 2016, 15, 364.
(28) 703Doh, H.; Hwang, S.; Kim, S. Size-Tunable Synthesis of Nearly
704Monodisperse Ag2S Nanoparticles and Size-Dependent Fate of the
705Crystal Structures upon Cation Exchange to AgInS2 Nanoparticles.
706Chem. Mater. 2016, 28, 8123−8127.
(29) 707Ruiz, D.; del Rosal, B.; Acebroń, M.; Palencia, C.; Sun, C.;
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